VKTX: Viking Therapeutics, Inc. Price Chart

Brandmark of Viking Therapeutics Corp (VKTX)

The price chart for Viking Therapeutics (VKTX) illustrates the asset's dynamics, with indicators currently at 26.79. The business relies on the development of GLP-1 peptides, where the active research stage could create massive financial leverage and high profits driven by patent protection. Viking Therapeutics (VKTX) is developing innovative treatments for MASH and obesity while strictly adhering to environmental waste disposal regulations.

vikingtherapeutics.com - VKTX Price (period 07/04/2022 - 11/18/2026)

Viking Pharma (VKTX) - metric breakdowns and financial figures

- current price and projected stock value:
- market capitalization information:
Analysis of all company metrics:vikingtherapeutics.com VKTX
Signature product of Viking Therapeutics Inc

The price reflects the market value of the asset, which is re-evaluated under the influence of macroeconomic cycles and interest rates. For Viking Therapeutics (VKTX), this metric accumulates expectations of future pricing power upon the market launch of obesity drugs. By analyzing the current share price, an investor can identify early signs of a trend reversal. The price action tests the fundamental resilience of the business. Growth in value requires confirmation of clinical trial efficacy.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|Supernus Pharma (SUPN) - Price Chart|Share Price CPRX|Price Chart Denali Therapeutics|Share Price HRMY (Harmony Pharma)|Stock Price BHVN|AMLX - Market Price|trevitherapeutics.com - Stock Quotes|Stock Price Praxis Precision Medicines Inc PRAX|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel